162 related articles for article (PubMed ID: 3674050)
1. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.
Caputo GM; Archer GL; Calderwood SB; DiNubile MJ; Karchmer AW
Am J Med; 1987 Oct; 83(4):619-25. PubMed ID: 3674050
[TBL] [Abstract][Full Text] [Related]
2. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease.
Miele PS; Kogulan PK; Levy CS; Goldstein S; Marcus KA; Smith MA; Rosenthal J; Croxton M; Gill VJ; Lucey DR
Am Heart J; 2001 Oct; 142(4):571-6. PubMed ID: 11579344
[TBL] [Abstract][Full Text] [Related]
3. [Endocarditis of a natural valve caused by coagulase-negative staphylococci].
Aguado García JM; Fernández Guerrero ML; Riancho Moral JA; Martín Durán R; Ochoteco A
Med Clin (Barc); 1989 Jun; 93(3):93-6. PubMed ID: 2796434
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
Karchmer AW; Archer GL; Dismukes WE
Ann Intern Med; 1983 Apr; 98(4):447-55. PubMed ID: 6838067
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.
Duah M
Ann Clin Microbiol Antimicrob; 2010 Feb; 9():9. PubMed ID: 20167084
[TBL] [Abstract][Full Text] [Related]
6. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
7. Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations.
Whitener C; Caputo GM; Weitekamp MR; Karchmer AW
Infect Dis Clin North Am; 1993 Mar; 7(1):81-96. PubMed ID: 8463655
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.
Karchmer AW
Am J Med; 1985 Jun; 78(6B):116-27. PubMed ID: 3893113
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus capitis endocarditis: two cases and review of the literature.
Sandoe JA; Kerr KG; Reynolds GW; Jain S
Heart; 1999 Sep; 82(3):e1. PubMed ID: 10455099
[TBL] [Abstract][Full Text] [Related]
10. [Current profile of left-sided native valve endocarditis caused by coagulase-negative Staphylococcus].
Revilla A; San Román JA; López J; Vilacosta I; Luaces M; Fernández-Avilés F
Rev Esp Cardiol; 2005 Jun; 58(6):749-52. PubMed ID: 15970127
[TBL] [Abstract][Full Text] [Related]
11. Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study.
Etienne J; Eykyn SJ
Br Heart J; 1990 Dec; 64(6):381-4. PubMed ID: 2271345
[TBL] [Abstract][Full Text] [Related]
12. Japanese features of native valve endocarditis caused by coagulase-negative staphylococci: case reports and a literature review.
Nishizaki Y; Yamagami S; Joki Y; Takahashi S; Sesoko M; Yamashita H; Yokoyama T; Uehara Y; Daida H
Intern Med; 2013; 52(5):567-72. PubMed ID: 23448766
[TBL] [Abstract][Full Text] [Related]
13. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
Karchmer AW; Archer GL; Dismukes WE
Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
[TBL] [Abstract][Full Text] [Related]
14. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
[TBL] [Abstract][Full Text] [Related]
15. Rapidly destructive Staphylococcus epidermidis endocarditis.
Zinkernagel AS; Speck RF; Ruef C; Zingg W; Berger-Bachi B; Springer B
Infection; 2005 Jun; 33(3):148-50. PubMed ID: 15940416
[TBL] [Abstract][Full Text] [Related]
16. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
Fadel HJ; Tleyjeh IM; Steckelberg JM; Wilson WR; Baddour LM
Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1395-8. PubMed ID: 19705174
[TBL] [Abstract][Full Text] [Related]
18. Coagulase-negative staphylococcal endocarditis. Occurrence in patients with mitral valve prolapse.
Baddour LM; Phillips TN; Bisno AL
Arch Intern Med; 1986 Jan; 146(1):119-21. PubMed ID: 3942444
[TBL] [Abstract][Full Text] [Related]
19. [Aminoglycosides in the treatment of infectious endocarditis].
Malinverni R
Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]